Department of Ophthalmology, Massachusetts Eye and Ear Infirmary, Harvard Medical School, Boston, MA, USA.
Boston University, School of Medicine, Boston, MA, USA.
Surv Ophthalmol. 2022 Jul-Aug;67(4):1160-1174. doi: 10.1016/j.survophthal.2021.11.008. Epub 2021 Nov 21.
Oculomotor nerve schwannomas are rare benign cranial nerve tumors. There are only a limited number of reports on this pathology in the literature, and there are currently no established management guidelines that aid providers in deciding on surgical versus nonsurgical management. We assess the published literature on the topic to identify indications for treatment as well as outcome measures (e.g., local control rates, survival rates, and complication rates) that have been reported as associated with the various treatment modalities. We attempt to develop an algorithm for evaluation and treatment of oculomotor nerve schwannomas in order to establish consensus on how these tumors should be treated.
动眼神经鞘瘤是一种罕见的良性颅神经肿瘤。在文献中，只有少数关于这种病理学的报道，目前还没有既定的管理指南来帮助医生决定手术治疗还是非手术治疗。我们评估了该主题的已发表文献，以确定与各种治疗方法相关的治疗指征和结果衡量标准（例如局部控制率、生存率和并发症发生率）。我们试图制定动眼神经鞘瘤的评估和治疗算法，以就如何治疗这些肿瘤达成共识。
